PTOV1表达水平对结直肠癌患者预后的影响

doi:10.16352/j.issn.1001-6325.2022.08.1176

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (8): 1176-1181.doi: 10.16352/j.issn.1001-6325.2022.08.1176

PTOV1表达水平对结直肠癌患者预后的影响

谢思安¹, 陈奕阳², 徐俊玄¹, 宁婷婷¹, 张楠¹, 朱圣韬¹, 张澍田^1*

首都医科大学北京友谊医院 1.消化内科; 2.检验科,北京 100050

收稿日期:2021-09-05 修回日期:2022-06-26 出版日期:2022-08-05 发布日期:2022-08-01
通讯作者: ^*zhangshutian@ccmu.edu.cn
基金资助:
国家自然科学基金(82103394);首都医科大学附属北京友谊医院“友谊种子计划”人才项目(YYZZ202028)

Effect of PTOV1 expression on prognosis of colorectal cancer patients

XIE Si-an¹, CHEN Yi-yang², XU Jun-xuan¹, NING Ting-ting¹, ZHANG Nan¹, ZHU Sheng-tao¹, ZHANG Shu-tian^1*

1. Department of Gastroenterology; 2. Department of Laboratory Medicine, Beijing Friendship Hospital,Capital Medical University, Beijing 100050,China

Received:2021-09-05 Revised:2022-06-26 Online:2022-08-05 Published:2022-08-01
Contact: ^*zhangshutian@ccmu.edu.cn

摘要/Abstract

摘要： 目的基于生物信息学分析前列腺肿瘤过表达1 (PTOV1)在结直肠癌 (CRC)中的表达对CRC患者预后的影响,初步验证并探讨其对CRC细胞增殖的影响。方法结合生物信息学和生物学实验验证分析CRC组织及细胞系中PTOV1的表达情况;蛋白免疫印迹和RT-qPCR验证PTOV1表达变化;在SW480细胞系中敲低PTOV1后通过集落形成实验和EdU实验探讨PTOV1对CRC细胞增殖的影响。结果 PTOV1在CRC组织和细胞系中表达显著上调(P＜0.05);进一步通过生信学分析表明,PTOV1作为一个癌基因与CRC不良预后相关;体外实验表明敲低PTOV1表达抑制SW480细胞增殖(P＜0.05)。结论 PTOV1在CRC中高表达且与CRC患者不良预后相关,是CRC进展的潜在预后生物标志物。

关键词: 结直肠癌, PTOV1, 预后, 生物标志物, 增殖

Abstract: Objective To analyze the effect of over-expression of prostate tumor 1 (PTOV1) on the prognosis of colorectal cancer (CRC) based on bioinformatics, and to demonstrate the effect of PTOV1 on the proliferation of CRC cells. Methods Combined with bioinformatics and biological experiments, PTOV1 expression in CRC tissues and cell lines was analyzed. PTOV1 expression was confirmed by Western blot and RT-qPCR. The effect of PTOV1 on the proliferation of CRC cells was investigated by colony formation assay and EdU assay after transfection by PTOV1 siRNA in SW480 cell line. Results PTOV1 expression was significantly up-regulated in CRC tissues and cell lines (P＜0.05). More biological experiments results showed that PTOV1 as an oncogene was associated with poor prognosis of CRC. In vitro experiments showed that PTOV1 knockdown inhibited the proliferation of SW480 cells(P＜0.05). Conclusions PTOV1 is highly expressed in CRC and is associated with poor prognosis in CRC patients. PTOV1 is a potential prognostic biomarker for the progression of CRC.

Key words: colorectal cancer, PTOV1, prognosis, biomarkers, proliferation

中图分类号:

R735.7

谢思安, 陈奕阳, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 张澍田. PTOV1表达水平对结直肠癌患者预后的影响[J]. 基础医学与临床, 2022, 42(8): 1176-1181.

XIE Si-an, CHEN Yi-yang, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, ZHANG Shu-tian. Effect of PTOV1 expression on prognosis of colorectal cancer patients[J]. Basic & Clinical Medicine, 2022, 42(8): 1176-1181.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2022.08.1176

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2022/V42/I8/1176

参考文献 12

[1]	Tsukamoto S, Ishikawa T, Iida S, et al. Clinical significance of osteoprotegerin expression in human colorectal cancer[J]. Clin Cancer Res, 2011, 17:2444-2450.
[2]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71:209-249.
[3]	Benedit P, Paciucci R, Thomson TM, et al. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks[J]. Oncogene, 2001, 20:1455-1464.
[4]	Lei F, Zhang L, Li X, et al. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer[J]. BMC Cancer, 2014, 14:457. doi:10.1186/1471-2407-14-457.
[5]	Sinicrope FA. Increasing incidence of early-onset colorectal cancer[J]. N Engl J Med, 2022, 386:1547-1558.
[6]	Shen H, Liao B, Wan Z, et al. PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer[J]. Mol Ther Oncolytics, 2021, 20:499-507.
[7]	Wu Z, Liu Z, Jiang X, et al. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits[J]. J Exp Clin Cancer Res, 2019, 38:341. doi:10.1186/s13046-019-1349-y.
[8]	Karna SKL, Ahmad F, Lone BA, et al. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells[J]. PLoS One, 2019, 14:e0211658. doi:10.1371/journal.pone.0211658.
[9]	Morote J, Fernandez S, Alana L, et al. PTOV1 expres-sion predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy[J]. Clin Cancer Res, 2008, 14:2617-2622. doi:10.1158/1078-0432.CCR-07-4987.
[10]	Pennington KL, McEwan CM, Woods J, et al. SGK2, 14-3-3, and HUWE1 cooperate to control the localization, stability, and function of the oncoprotein PTOV1[J]. Mol Cancer Res, 2022, 20:231-243.
[11]	Santamaria A, Castellanos E, Gomez V, et al. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts[J]. Mol Cell Biol, 2005, 25:1900-1911.
[12]	Marques N, Sese M, Canovas V, et al. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1[J]. Oncogene, 2014, 33:1124-1134.

[1]	贺晶, 李艳, 王延峰, 鲍慧. FABP4表达上调促进人子宫内膜癌细胞系HEC-1-A增殖和迁移[J]. 基础医学与临床, 2022, 42(9): 1356-1361.
[2]	张晓雷, 刘静, 李朝萍. Circ_0032821参与索拉非尼抑制乳腺癌细胞系T47D增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(9): 1350-1354.
[3]	王娟, 张晓燕, 朱爱华, 于宏波, 范新丹, 汤春辉, 姚秀芳. Ku70高表达促进人卵巢癌细胞系的增值并与卵巢癌患者不良预后相关[J]. 基础医学与临床, 2022, 42(9): 1391-1399.
[4]	孙爱华, 赵艳秋, 王继灵. 老年慢性阻塞性肺部疾病急性加重期患者住院死亡的危险因素及预后[J]. 基础医学与临床, 2022, 42(9): 1414-1418.
[5]	沈永华, 汪峻峰, 程泽星, 冯娟娟. 秦皮甲素抑制人鼻咽癌细胞系HNE-3增殖[J]. 基础医学与临床, 2022, 42(8): 1237-1242.
[6]	樊佳赛, 杜艺菲, 许佳颖, 陈思臻, 高永桧, 任景怡. 基于中医证候和机器学习构建慢性心力衰竭中西医结合预后模型[J]. 基础医学与临床, 2022, 42(8): 1169-1175.
[7]	江宁, 郭钧, 刘铖, 周举. 莪术醇抑制人骨肉瘤细胞系的增殖和促凋亡[J]. 基础医学与临床, 2022, 42(8): 1200-1205.
[8]	刘磊, 李世宝, 张好良. 沉默lnc-SLC2A12-10:1抑制人胃癌细胞系AGS增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(7): 1071-1076.
[9]	康有力, 赵丹, 杜文静, 李莉. SIRT5通过调控ALDH5A1的琥珀酰化促进人乳腺癌细胞的增殖[J]. 基础医学与临床, 2022, 42(7): 1099-1107.
[10]	谢思安, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 刘思. VAV1是动脉粥样硬化预后的潜在靶点和生物标志物[J]. 基础医学与临床, 2022, 42(7): 1092-1098.
[11]	白冰, 张海芳, 杨庆良, 秦悦, 周晨龙, 宋歌, 王颖. 下调lncRNA RHPN1-AS1抑制人膀胱癌细胞系T24增殖和迁移[J]. 基础医学与临床, 2022, 42(6): 940-944.
[12]	武坤, 聂波, 李云涛, 杨金荣, 程沈菊, 李艳红, 史明霞. 外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用[J]. 基础医学与临床, 2022, 42(6): 871-875.
[13]	哈提米汗·买买提, 姑丽克孜·买买提热夏提, 李俞霆, 周常慧, 李榕. CBX7蛋白在宫颈癌中的表达及其临床意义[J]. 基础医学与临床, 2022, 42(5): 721-725.
[14]	何丹, 阮中宝. 细胞外囊泡在心房颤动发病中的作用[J]. 基础医学与临床, 2022, 42(4): 671-674.
[15]	苏路瑛, 黄容, 邹定峰, 许富, 李凯, 卢艳, 缪时英, 王琳芳, 宋伟. 多组学分析发现LAMC2是调节泛癌微环境的关键因子[J]. 基础医学与临床, 2022, 42(4): 545-552.

PTOV1表达水平对结直肠癌患者预后的影响

Effect of PTOV1 expression on prognosis of colorectal cancer patients

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 12

相关文章 15

编辑推荐

Metrics

本文评价